2024

LinusBio Wins 2024 BioTech Breakthrough Award for “Overall MedTech Company of the Year”

Read more
2024

LinusBio Bucks Market Slowdown, Secures Additional $8M in A2 Funding with Increased Valuation

2024

LinusBio Named “Fierce 15” Company of 2023 by Fierce Medtech

2023

LinusBio Raises $16 Million to Scale Growth and Deliver Tangible Outcomes

2022

Novozymes and LinusBio announce collaboration to accelerate scientific discovery in Biohealth

LinusBio Recognized at the 2022 Mount Sinai Innovation Awards

2022

WATCH: Detecting Autism at Birth and Opportunity for Early Intervention